Biotricity Files Patent Application for Revolutionary Biotres Device
Biotricity, a leading Technology-as-a-Service (TaaS) company in the remote cardiac monitor sector, has recently filed a patent application for its groundbreaking Biotres device. This innovative device incorporates proprietary 3 channel technology, multiple sensors, and a compact form factor, setting a new industry standard in remote patient monitoring and cardiac care.
The patent filing aims to protect Biotres’ unique features, including its ability to provide high-quality diagnosis through multiple ECG channels. Unlike previous compact devices, Biotres offers a comprehensive solution that addresses the limitations of single-channel monitors. By combining multiple sensors, architecture, and a compact form factor, Biotres enables early detection and proactive management of cardiac conditions.
Dr. Waqaas Al-Siddiq, CEO of Biotricity, emphasized the significance of this patent filing in expanding the company’s intellectual property (IP) portfolio and increasing market barriers. He stated, “As we consistently innovate and expand our IP and FDA 510(k) portfolios, we are not only winning market share and protecting our IP but continuously increasing the barriers to entry.”
Biotres represents a revolutionary leap forward in cardiac technology. This compact 3-channel connected cardiac monitor offers continuous, real-time data on vital signs, including heart rate, ECG, and activity levels. With up to 30 days of recording capacity, wireless connectivity, and automated data offloading, Biotres significantly reduces the time required for results, enabling faster clinician response.
The device also facilitates remote access to ECG data for physicians and allows patients to report symptoms through an intuitive app. This seamless integration of technology enhances patient outcomes, increases patient safety, and empowers healthcare providers with actionable insights.
Biotricity plans to continue filing patents as part of its IP strategy and expects to submit two additional patents within the next year. This commitment to innovation and intellectual property protection demonstrates the company’s dedication to redefining the cardiac care landscape.
To learn more about Biotricity’s cutting-edge solutions in cardiac care, including the Biotres device, visit their website at www.biotricity.com.
About Biotricity Inc.:
Biotricity Inc. is a leading healthcare company focused on bridging the gap in remote monitoring and chronic care management. With a commitment to preventive and personal care, Biotricity develops comprehensive remote health monitoring solutions for both medical and consumer markets.
Contact:
Investor Relations
Biotricity Investor Relations
Investors@biotricity.com
SOURCE: Biotricity, Inc.